Colostrum More Effective Than Flu Vaccine

One study found a combination of colostrum and probiotics is more effective in preventing flu than vaccination.1 Colostrum is a nutrient-rich fluid produced by mammals immediately after birth that helps provide immune protection to the baby. In addition to flu prevention, colostrum has other benefits to your overall health.

Many viral illnesses, like colds and flu, are seasonal. Although you can get sick anytime during the year, in the U.S. colds and flu are more prevalent from October through March. There are a variety of reasons that happens, not the least of which is related to your sun exposure and subsequent vitamin D production.

The burden influenza has on society changes each year, as the virulence of the flu strain also changes. In the 2018 to 2019 season, the U.S. Centers for Disease Control and Prevention estimated 35.5 million people would be sick with flu in the U.S., resulting in 490,600 hospitalizations and 34,200 deaths.2 This was lower than the 2017 to 2018 season when 45 million were sick and 61,000 died.3

In an effort to reduce the effect flu has on the general population, many experts recommend you get a flu shot each year. Yet, this strategy has not been effective and does not warrant the massive public media push it gets each fall. Thankfully, you have other choices to support your immune system and significantly reduce the potential you’ll get sick.

Probiotic and Colostrum More Effective Than Vaccine

The endpoint measurement for success in vaccinations should be the prevention of the illness or condition. One published study compared the effectiveness of the combination of colostrum and Bifivir against flu vaccination in the prevention of flu in participants.4 Bifivir is a supplement containing five strains of bacteria and prebiotic fiber.

In one study published in the Journal of Clinical Gastroenterology, the combination of probiotics and prebiotics in supplement form demonstrated effectiveness in “reducing the incidence and severity of respiratory diseases during the cold season.”5

In the study comparing the effectiveness of a combination of colostrum and Bifivir against flu vaccines, four groups of individuals were matched for age and sex distribution.6 In the control group, participants did not receive any preventive measures, which resulted in eight major episodes and 12 minor episodes of flu.

Those who received only the vaccine showed a similar response with eight major episodes and 13 minor episodes. In the group receiving the flu vaccine and the immunomodulators Bifivir and colostrum, there were four who had a major episode and nine with a minor episode.

The group that received only the immunomodulators faired the best. There were three with a major episode and eight with a minor episode. The researchers found the groups who received vaccinations and the immunomodulator and the group that received only the immunomodulators showed significantly lower rates of flu when compared against the other two groups.

Interestingly, in those who were vaccinated the number of days they had the flu was two times higher when compared against the other groups. There was no problem tolerating the immunomodulators and no side effects were found during the study.

The researchers concluded, “the administration of immunomodulators is very cost-effective and appears to be more effective than vaccination to prevent flu.”7

More Evidence Colostrum Benefits Your Immune System

This was not the first study to evaluate the effectiveness of colostrum on the immune system, nor was it the last. Bovine colostrum has been used to treat infections in the gastrointestinal tract and has been shown to support the immune system, musculoskeletal repair and growth.8

A significant portion of bovine colostrum survives the gastrointestinal tract and remains active in the lower intestines, where it impacts gut and immune health. It has proven safe, except for those who are allergic to milk, in whom it triggers an allergic reaction.9 One study analyzed the influence bovine colostrum had on the immune system of a group of highly trained road cyclists.10

The group was initially tested with a 40-kilometer (24.8 miles) time trial and then randomized to receive the intervention or to a control group. After five weeks of receiving the supplement, cyclists underwent another time trial and then completed five consecutive days of high-intensity training including a time trial at completion and another the following week.

The researchers collected blood before and after each time trial and any upper respiratory symptoms were recorded. The cyclists receiving the bovine colostrum supplementation showed a modulation of the immune parameters measured and a trend toward reduced upper respiratory symptoms.

More recently, a paper in Frontiers in Nutrition reviewed the current literature on the effect bovine immunoglobulin has on the human immune system.11 They describe the mechanism by which IgG from bovine colostrum neutralizes experimental infection, limits inflammation and binds to pathogens and allergens.

They offer these mechanisms as an explanation of the effect bovine IgG from colostrum can have on humans and believe it offers an approach to supporting the immune system in vulnerable groups, including the elderly and immunocompromised.

Colostrum Boosts Natural Killer Cells

Bovine colostrum raises the percentage of natural killer (NK) cells in the body.12 NK cells are a type of white blood cell and part of the innate immune system that helps control microbial infections and tissue damage.13 They also play a role in organ transplant, immunotherapy and autoimmune disorders.

NK cells are a type of lymphocyte that respond quickly to pathogens in the body. They are best known for attacking viruses and controlling early cancer cells. The NK cells secrete cytokines that signal other immune cells and ultimately enhance your immune response.

Scientists have found these cells can adapt and develop memory cells, which offers new insights into the role they play in the innate immune response protecting human health. These cells make up to 15% of the peripheral blood supply, but the majority are found in the spleen, bone marrow and lymph nodes.14

NK cell activity goes beyond immune surveillance and is activated with exposure to protein allergens. They can promote allergic sensitization and are involved in airway hyperresponsiveness. When the infection happens with an active allergic response, the NK cells raise the magnitude and contribute to the exacerbation of asthma.15

Flu Vaccine Fails Older Adults

Over 70% of respiratory flu-like illnesses during flu season are not caused by type A or type B influenza.16 Therefore, even if a flu shot is highly effective, it still cannot prevent the vast majority of respiratory infections that occur during flu season. However, the effectiveness of the flu vaccine typically does not reach a level of being highly effective.

This may be related to the hundreds of flu viruses and the constant changes they undergo. This means each year health officials make an educated guess about the strains most likely to be circulating in the upcoming season. Three or four type A and type B flu viruses are chosen and added to the seasonal flu shot.

This accounts for the varying and often disappointing results from the vaccine. It’s often stated that flu vaccinations will reduce hospitalizations and deaths in the elderly,17,18 but a 2020 study published in the Annals of Internal Medicine calls this statement into serious question.19

The researchers reviewed data from 170 million episodes of care and 7.6 million deaths in adults aged 55 to 75 between 2000 and 2014. The goal was to determine the effectiveness of the flu vaccine in elderly people living in England and Wales. The researchers concluded:20

“Current vaccination strategies prioritizing elderly persons may be less effective than believed at reducing serious morbidity and mortality in this population, which suggests that supplementary strategies may be necessary.”

Historically, regardless of how well-matched the vaccine is to circulating strains, your chances of getting influenza after vaccination are still greater than 50/50 in any given year.

According to CDC data updated September 10, 2019, the 2018/2019 flu vaccine (all vaccine types) against influenza A or B viruses had an adjusted effectiveness rating of 29% for all ages. When broken down by age group, only young children came close to 50% effectiveness, which raised the overall effectiveness percentage above all other age groups:21

  • 48% for children aged 6 months through 8 years
  • 7% for children ages 9 through 17
  • 25% for adults between the ages of 18 and 49
  • 14% for those 50 to 64
  • 12% for those over 65

Boost Your NK Cells Naturally

It’s important to remember you can take control of your health and support your immune system so you don’t need to rely on drug interventions against viral illnesses. The medical term for the degeneration of NK cells as you age is “immune senescence.” This leaves you susceptible to disease, but the good news is you can counter this decline in several natural ways, including:

Regular exercise — In one study, moderate exercise improved NK cell function in cancer patients.22

Quit smoking — Quitting doesn’t increase production of NK cells but improves function since smoking impairs NK cell capacity.23

Enzymatically modified rice bran (EMRB) — EMRB is produced by exposing rice bran fiber to enzymes isolated from the shiitake mushroom. In one study, a product from enzymatically modified arabinoxylan rice bran called MGN-3 demonstrated a “clear increase” in NK cell activity in patients with multiple myeloma after three months of treatment.24 

Cardamom and black pepper — A relative of turmeric, cardamom is known for its potent immune-boosting benefits. Cardamom and black pepper have shown the ability to enhance the cytotoxic activity of NK cell.25

Colostrum — Colostrum from cows is markedly similar to human colostrum, and colostrum products are typically derived from cows. The colostrum contains an array of immune and growth factors required by the offspring.

An animal study showed oral administration of skimmed and concentrated bovine late colostrum activated the immune system and protected against influenza infection by boosting NK cell activity.26

Mushrooms — Beta-glucans, found in mushrooms such as shiitake, maitake and oyster mushrooms, also boost NK cell activity.27,28

Active hexose correlated compound (AHCC) — AHCC is a commercially available fermented mushroom extract that supports healthy immune function, primarily by enhancing NK cell activity.29

Probiotics — Beneficial bacteria found in traditionally fermented foods boost NK cell activity.30 Those with low NK cell levels tend to experience greater benefits from probiotic supplementation than those with healthy levels of NK cells.

Ginseng — Panax ginseng, also known as Asian ginseng, stimulates NK cells and stimulates cytokines that lower the proinflammatory response.31 

Melatonin — Melatonin is a neurohormone produced by your pineal gland and stimulates the production of NK cells and the release of cytokines.32,33 Consider the strategies listed in “Melatonin — A Standard Treatment Adjunct for COVID-19?” to naturally raise your melatonin levels.

Lawsuits Begin Over SARS-CoV-2 Lab Leak

U.S. Right to Know (USRTK), an investigative public health nonprofit group, has filed a lawsuit1 against the National Institutes of Health after the agency failed to respond to the USRTK’s July 10, 2020, Freedom of Information Act (FOIA) request. According to the NIH, records were withheld due to them being part of an ongoing legal investigation.

The USRTK’s lawsuit seeks access to nonexempt records of gain-of-function experiments relating to the COVID-19 pandemic from the Wuhan Institute of Virology and the Wuhan Center for Disease Control and Prevention, as well as the EcoHealth Alliance, which partnered with and funded the Wuhan Institute.2 According to the USRTK’s November 5, 2020 press release:3

“Today’s litigation against the NIH is one part of our efforts to try to uncover what is known about the origins of SARS-CoV-2, and the risks of biosafety labs and gain-of-function research, which seeks to augment the infectivity or lethality of potential pandemic pathogens. Since July, we have filed 36 state, federal and international public records requests about these subjects.”

Flawed Studies Form Base of Zoonotic Theory

USRTK is also concerned about new claims that PLOS Pathogens and Nature published key papers on the origin of SARS-CoV-2 despite being flawed. I discussed these disturbing findings in “Top Medical Journal Caught in Massive Cover-Up.” It appears data sets were changed without notices of correction being published.

November 9, 2020, USRTK published a series of emails4 they’d sent to the lead authors and editors of the papers in dispute. The questions raised5 by the responses they received “put in doubt the validity of these key studies,” USRTK writes. As noted by USRTK reporter Carey Gillam:6

“Chinese governmental authorities first promoted the idea that the source of the causal agent for COVID-19 in humans came from a wild animal in December. Chinese government-supported scientists then backed that theory in four separate studies submitted to the journals between February 7 and 18 …

The four papers in question are Liu et al.,7 Xiao et al.,8 Lam et al.9 and Zhang et al.10 The two that are currently being investigated by the journal editors are Liu et al and Xiao et al. In communications with the authors and journal editors of those two papers, USRTK has learned of serious problems with the publication of those studies, including the following:

Liu et al. did not publish or share (upon being asked) raw and/or missing data that would allow experts to independently verify their genomic analyses.

Editors at both Nature and PLoS Pathogens, as well as Professor Stanley Perlman, the editor of Liu et al., have acknowledged in email communications that they are aware of serious issues with these papers and that the journals are investigating them. Yet, they have made no public disclosure of the potential problems with the papers.

… The problems with the research papers raise ‘serious questions and concerns’ about the validity of the zoonotic theory overall, according to Dr. Sainath Suryanarayanan, a biologist and sociologist of science, and USRTK staff scientist.”

Why We Need to Know the Origin of SARS-CoV-2

In a November 3, 2020, PNAS opinion,11 Dr. David Relman — a microbiologist and professor of medicine, microbiology and immunology at Stanford12 — explains why it’s so important to identify the origin of SARS-CoV-2:  

“SARS-CoV-2 is a betacoronavirus whose apparent closest relatives, RaTG13 and RmYN02, are reported to have been collected from bats in 2013 and 2019, respectively, in Yunnan Province, China. COVID-19 was first reported in December 2019 more than 1,000 miles away in Wuhan City, Hubei Province, China.

Beyond these facts, the ‘origin story’ is missing many key details, including a plausible and suitably detailed recent evolutionary history of the virus, the identity and provenance of its most recent ancestors, and surprisingly, the place, time, and mechanism of transmission of the first human infection.

Even though a definitive answer may not be forthcoming, and even though an objective analysis requires addressing some uncomfortable possibilities, it is crucial that we pursue this question. Preventing the next pandemic depends on understanding the origins of this one …

If we find more concrete evidence of a ‘spill-over’ event with SARS-CoV-2 passing directly from bat to human, then efforts to understand and manage the bat-human interface need to be significantly strengthened. But if SARS-CoV-2 escaped from a lab to cause the pandemic, it will become critical to understand the chain of events and prevent this from happening again.”

Relman goes on to review the top three contending origin hypotheses:

  • The virus evolved in bats and then spread directly or via an intermediate host to humans through natural mechanisms
  • SARS-CoV-2, or a recent ancestor, was collected from an infected animal and then either knowingly or accidentally propagated or genetically manipulated before accidental release
  • SARS-CoV-2 was deliberately engineered through gain-of-function research on coronaviruses, and was intentionally released

As noted by Relman, we’ve thus far been unable to identify the immediate parent or parents of SARS-CoV-2, and this is a key piece of information needed to unlock the full puzzle. The two closest relatives — RaTG13 and RmYN02 — aren’t close enough to have mutated into SARS-CoV-2.  

It’s quite possible that there is more than one ancestral lineage. Recombination between different viruses is common both in nature and in laboratory research, and to determine which route the virus took, we need to identify the starting point. Relman’s opinion ends with the following comment:13

“A more complete understanding of the origins of COVID-19 clearly serves the interests of every person in every country on this planet. It will limit further recriminations and diminish the likelihood of conflict; it will lead to more effective responses to this pandemic, as well as efforts to anticipate and prevent the next one.

It will also advance our discussions about risky science. And it will do something else: Delineating COVID-19’s origin story will help elucidate the nature of our very precarious coexistence within the biosphere.

Unfortunately, evidence suggests data scrubbing and cover-ups have already occurred, which makes establishing SARS-CoV-2’s origin all the more difficult. The question is, why was this done?

Was there a political purpose behind it? Was this a purposely engineered virus released to provide justification for the globalist “reset” plan? Was it an accidental release that was covered up to protect the future existence of dangerous gain-of-function research?

Indeed, pinpointing the virus’ origin is key to answering these important questions, and no one but the ones responsible for the attempted cover-up have anything to gain from shielding the public from the truth, whatever it might be.

Anomalies Abound

I’ve written several articles about the various hypotheses surrounding the origin of SARS-CoV-2. Importantly, anomalies in its genetic structure lean toward it being a genetically manipulated virus, although the exact method remains unknown. What we do know is that there are many ways — including low-tech ones — in which a virus such as SARS-CoV-2 could have been created.

According to the August 2, 2020, paper14 “HIV Man-Manipulated Coronavirus Genome Evolution Trends,” written by Nobel Laureate professor Luc Montagnier and mathematician Jean Claude Perez, HIV/SIV sequences have been identified in a small localized region of SARS-CoV-2’s genome that allows the virus to infect human cells.

“This region has been ‘manipulated’ by humans,” the authors state, adding that since deletions in this region have been observed in COVID-19 patients, “we can expect a faster genetic evolution of the virus toward a less pathogenic strain lacking this human-made region.”

Montagnier, who received the Nobel Prize in medicine for his co-discovery of the HIV virus,15 has previously gone on record stating he believes SARS-CoV-2 was manipulated — as it has elements of HIV in its genome — and that it was likely released by accident.16,17

In an April 2020 interview with the French media outlet CNews,18 Montagnier stated he believes “the HIV sequence was inserted into the genome of the coronavirus in an attempt to make an HIV vaccine.” According to Montagnier and Perez, SARS-CoV-2’s master code “shows optimal spike PRRA site inserts” that are also shared with RaTG13.19,20

Again, RaTG13 is one of the most closely related viruses to SARS-CoV-2. It was discovered by the Wuhan Institute of Virology in 2013 after it was reported that six miners had contracted a mysterious viral infection that resulted in severe pneumonia. Three of the miners died. Montagnier and Perez write:21

“In the comparative analysis of both SPIKES genes of COVID-19 [i.e., SARS-CoV-2] and Bat RaTG13, we note two abnormal facts:

1. The insertion of 4 contiguous PRRA amino acids in the middle of SPIKE (then we show that this site was already an optimal cleavage site BEFORE this insertion).

2. An abnormal ratio of synonymous codons / non synonymous codons in the second half of SPIKE.

Finally, we show the insertion in this 1770 bases SPIKE region of a significant EIE [external informative element] from Plasmodium Yoelii and of a possible HIV1 EIE with a crucial Spike mutation.

Through the 14 facts relating to each of the 14 paragraphs of this article, everything converges towards possible laboratory manipulations, which contributed to modifications of the genome of COVID-19, but also, very probably much older SARS, with perhaps this double objective of vaccine design and of ‘gain of function’ in terms of penetration of this virus into the cell.”

A study22 posted on the preprint server bioRxiv July 21, 2020 also discussed the PRRA found both in the RaTG13 spike and the SARS-CoV-2 spike:

“Strikingly, insertion of PRRA into the raTG13 Spike selectively abrogated the usage of horseshoe bat and pangolin ACE2 but conferred usage of mouse ACE2 by the relevant pseudovirus to enter cells …

The implications of this finding are twofold: First, if SARS-CoV-2 and raTG13 share the same ancestor which originates from horseshoe bat, it is likely that acquisition of PRAA would render this bat ancestor virus less efficient infecting horseshoe bat, hence the virus would have to find a new host. Secondly, insertion of PRRA may have a previously unrecognized impact on Spike-ACE2 interaction …

Modeling SARS-CoV-2 Spike and mouse ACE2 interaction predicts that mouse ACE2 is unlikely to support entry, which has been widely verified in experiments …

Our findings, however, suggest raTG13 Spike may adopt a different conformation from SARS-CoV-2 Spike and the presence of PRRA may subtly modulate the binding of its RBD [receptor binding domain] to ACE2 of horseshoe bat, pangolin and mouse.

In summary, we showed that spike proteins from all three viruses, SARS-CoV-2, bat CoV raTG13, and CoV-pangolin/GX, have the potential to mediate entry using ACE2 from multiple animal species besides human. The PRRA insertion selectively allows SARS-CoV-2 to infect human lung cell line Calu-3 and unexpected altered dependence of raTG13 Spike on ACE2 of three species.”

Is SARS-CoV-2 the Result of Passage Through Transgenic Mice?

This leads us to yet another possibility, namely that the SARS-CoV-2 virus might be the result of RaTG13 (or another close ancestor virus) being passed through transgenic mice equipped with human ACE2 receptors.

As reported by The Jackson Laboratory,23 structural differences between the mouse ACE2 and the human ACE2 proteins make regular lab mice unsuitable for research relating to SARS-CoV-2, as the virus cannot readily infect them.

However, there are transgenic mice that express human ACE2. The first of these transgenic mice, known as K18-hACE2, were developed in 2007. Other transgenic mice with human ACE2 have been created since then. At least two recent studies have shown that transgenic mice with human ACE2 are easily infected and killed by SARS-CoV-2:

  • The first, published in the July 8, 2020, issue of Cell Host & Microbe found transgenic mice with human ACE2 of all ages had far higher viral loads in the lungs, trachea and brain than wild-type mice. While none died, older transgenic mice infected with SARS-CoV-2 came down with pneumonia and had elevated cytokines. The virus was found to produce “productive infection” both via intranasal and intragastric infection.24
  • The second, published in the July 9, 2020, issue of the journal Cell found SARS-CoV-2 infected HFH4-hACE2 transgenic mice, causing death. The infection was primarily localized to the lungs, causing interstitial pneumonia similar to that seen in COVID-19 patients. Low levels of viral RNA were also found in the eyes, heart and brain in a small number of animals.25

In response26 to questions for a July 31, 2020 Science article, Wuhan Institute of Virology coronavirus researcher Dr. Shi Zhengli stated that:27,28

“We performed in vivo experiments in transgenic (human ACE2 expressing) mice and civets in 2018 and 2019 in the Institute’s biosafety laboratory. The viruses we used were bat SARSr-CoV close to SARS-CoV …

The results suggested that bat SARSr-CoV can directly infect civets and can also infect mice with human ACE2 receptors. Yet it showed low pathogenicity in mice and no pathogenicity in civets. These data are being sorted and will be published soon”.

So, in summary, Zhengli admits experiments were done on transgenic mice using a bat-derived SARS-related coronavirus, which closely resembles SARS-CoV, in 2018 and 2019. (SARS-CoV is the virus responsible for severe acute respiratory syndrome (SARS), that broke out in 2003.)

Could this be the missing intermediate species that explains why SARS-CoV-2 is so well-adapted to infecting humans via the ACE2 receptor? It’s still too early to tell, but it’s a possibility. Of course, this does not exclude the possibility that other engineering methods were also used.

Foxes Guard the Henhouse

After months of stonewalling, investigative commissions are now being launched,29,30 ostensibly to get to the bottom of SARS-CoV-2’s origin. Whether they will actually unearth the truth or simply bury it deeper remains to be seen, but based on key members’ clear conflicts of interests, it doesn’t look promising.

For example, The Lancet’s COVID-19 Commission is being led by Dr. Peter Daszak.31 Not only has Daszak already spoken out about his conviction that the virus is natural and shunned theories to the contrary, as the president of the EcoHealth Alliance he’s also deeply conflicted from a business standpoint, seeing how EcoHealth Alliance received grants from the NIH for coronavirus research that was then subcontracted to the Wuhan Institute of Virology.

Daszak has every reason to make sure SARS-CoV-2 ends up being declared natural, because if it turns out to be a lab-creation, his own livelihood as a scientist is at stake. It would be naïve to believe that safeguarding the continuation of dangerous gain-of-function research wouldn’t be a powerful motivator to preserve the zoonotic origin narrative.

All-powerful CDC calls for concentration camps in America, including the invasion of homes and neighborhoods

(Natural News) The mass surrender of individual liberties and property rights in 2020 has emboldened a dangerous merger between power-drunk government officials and public health authoritarians. An all-powerful Centers for Disease Control (CDC) is now plotting to turn American communities into concentration camps using a variety of family separation strategies. These concentration camps are justified…

Georgia “audit” fake, ballot recount rigged

(Natural News) The statewide audit and hand recount of ballots that was requested and granted in the state of Georgia turned out to be nothing but a farce after Secretary of State Brad Raffensperger rigged it to reproduce the same fraudulent, pro-Biden results. In a joint letter, the Georgia Republican Party and The Donald J….

Under the skin: humans develop extra muscles which vanish before birth, scientists say

(Natural News) Researchers from Howard University and the Vision Institute in Paris found that humans develop extra muscles in their hands and feet in the womb that later disappear before birth. The researchers examined images showing the initial stages of human muscle development and found that extra muscular tissues were growing weeks after conception. These tissues, as reported…